29 March 2017 - Board Changes
29 March 2017
READING, UNITED KINGDOM (29 March 2017) — Convatec Group Plc ("Convatec" or the "Company") announces that further to the sale of shares in the Company by Nordic Capital and Avista (as defined below), which they have announced separately today, Thomas Vetander and Kunal Pandit who are nominated directors of Nordic Capital and Avista, respectively, have tendered their resignations from the Board, effective from 31 March 2017.
Enquiries
Convatec
Bobby Leach, VP Group Corporate Affairs, Convatec +44 (0)7770 842 226
Kirsty Law, Director Investor Relations +44 (0)7470 909 582
Finsbury
Rebecca Fitchett +44 (0)207 251 3801
About Convatec
Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about Convatec, please visit www.convatecgroup.com where a copy of this announcement can also be found.
“Nordic Capital” refers to Nordic Capital VII Limited, acting in its capacity as General Partner of Nordic Capital VII Alpha, L.P. and Nordic Capital VII Beta, L.P. together with associated co-investment vehicles and Nordic Capital VI Limited, acting in its capacity as General Partner of Nordic Capital VI Alpha, L.P. and Nordic Capital VI Beta, L.P. together with associated co-investment vehicles.
“Avista” is the limited liability companies and limited partnerships managed by Avista Capital Managing Member, LLC with interests in ConvaTec, including Avista Capital Partners LP, Avista Capital Partners II LP and their affiliated funds and co-invest vehicles.
Download PRESS RELEASE
PDF
Press Release
04-Dec-17
Corporate
Our People
Organisation Appointments
Organisation Appointments
Read more Read more16-Oct-17
Corporate
Financial Performance
FY2017 guidance and third quarter update
FY2017 guidance and third quarter update
Read more Read more19-Sep-17
Continence Care
Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for ...
Convatec Introduces GentleCath™ Glide and me+™ Continence Care Programme for Intermittent Catheter Users in Europe
Read more Read more21-Aug-17
Corporate
Our People
Appointment to Executive Committee
Appointment to Executive Committee
Read more Read more14-Aug-17
Corporate
Our People
Convatec appoints two Non-Executive Directors
Convatec appoints two Non-Executive Directors
Read more Read more03-Aug-17
Ostomy Care
Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy P...
Convatec Launches Natura™ Convex Accordion Flange™, Designed to Make Ostomy Pouch Application Easier and More Comfort...
Read more Read more03-Aug-17
Corporate
Convatec Announces 2017 Interim results
Convatec Announces 2017 Interim results
Read more Read more20-Jul-17
Corporate
Continence Care
Convatec Announces Acquisition of Woodbury Holdings
Convatec Announces Acquisition of Woodbury Holdings
Read more Read more09-Jun-17
Corporate
Our People
Announcement on Board of Directors
Announcement on Board of Directors
Read more Read more04-May-17
Corporate
Financial Performance
Trading Update for the three months ended 31 March 2017
Trading Update for the three months ended 31 March 2017
Read more Read more02-May-17
Ostomy Care
Convatec Announces U.S. FDA 510(k) Clearance and Launch of Flexi-Seal™ PROTEC...
Convatec Announces U.S. FDA 510(k) Clearance and Launch of Flexi-Seal™ PROTECT Fecal Management System
Read more Read more07-Apr-17
Advanced Wound Care
Independent Study Finds Significant Decrease in Post-Operative Joint Infectio...
Independent Study Finds Significant Decrease in Post-Operative Joint Infections with AQUACEL® Ag SURGICAL Cover Dressing
Read more Read more